AIG
RXRX icon

American International Group’s Recursion Pharmaceuticals RXRX Stock Holding History

American International Group’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-68,660
Closed -$685K – 2200
2024
Q1 		$685K Buy
68,660
+823
+1% +$9.16K ﹤0.01% 1501
2023
Q4 		$669K Sell
67,837
-275
-0.4% -$1.96K ﹤0.01% 1503
2023
Q3 		$521K Buy
68,112
+2,422
+4% +$24.2K ﹤0.01% 1580
2023
Q2 		$491K Sell
65,690
-266
-0.4% -$1.86K ﹤0.01% 1655
2023
Q1 		$440K Buy
65,956
+1,311
+2% +$10.4K ﹤0.01% 1668
2022
Q4 		$498K Sell
64,645
-235
-0.4% -$2.31K ﹤0.01% 1591
2022
Q3 		$690K Buy
64,880
+1,589
+3% +$16.1K 0.01% 1383
2022
Q2 		$515K Buy
63,291
+6,066
+11% +$40.6K ﹤0.01% 1587
2022
Q1 		$410K Sell
57,225
-4,026
-7% -$42.8K ﹤0.01% 1836
2021
Q4 		$1.05M Buy
61,251
+45,851
+298% +$863K 0.01% 1405
2021
Q3 		$354K Buy
15,400
+3,561
+30% +$101K ﹤0.01% 2075
2021
Q2 		$432 Buy
+11,839
New +$350K ﹤0.01% 2014

Other funds holding RXRX

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American International Group's RXRX Position: Q2 2024 in Review

American International Group sold out of Recursion Pharmaceuticals (RXRX) in Q2 2024, closing a stake of 68,660 shares — an estimated $685K sold.

American International Group first reported a position in RXRX in Q2 2021 and held it in 12 quarters. The position peaked at $1.05M in Q4 2021. 270 funds tracked by Wall St. Rank hold RXRX as of Q2 2024.

  • American International Group reported no remaining Recursion Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 68,660 Recursion Pharmaceuticals shares in Q2 2024, an estimated $685K.
  • American International Group first reported a position in Recursion Pharmaceuticals in Q2 2021 and held it in 12 quarters.
  • American International Group's Recursion Pharmaceuticals position peaked at $1.05M in Q4 2021.
  • 270 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.